Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
disc medicine
Find current coverage on disc medicine, including stock moves, FDA catalysts, and executive changes. Understand how these developments may affect risk, timing, and returns in biotech investing.
3 articles
Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Disc Medicine Stock Swinging, Yet a Fund Bet Shines
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...